Company Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

VCANBIO CELL & GENE ENGINEERING CORP., LTD

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 29/04/2024 BST			5-day change	1st Jan Change
17.8 ^CNY	+4.89%		+9.00%	-12.19%

04-25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

VCANBIO CELL & GENE ENGINEERING CORP., LTD is a China-based company, principally engaged in the preparation, detection and storage of cells. The Company is also engaged in cell culture and gene detection and storage, as well as the production and sale of cytokines culture solutions, cosmetics and detection reagents. The Company conducts its businesses mainly within domestic markets.

Number of employees: 2,332

CNY in Million	2022	Weight	2023	Weight	Delta
Reagents and Medical Equipment 67.9 %	1,033	66.4 %	1,079	67.9 %	+4.43%
Stem Cell-related Business 32.1 %	522	33.6 %	511	32.1 %	-2.10%

CNY in Million	2022	Weight	2023	Weight	Delta
China 76.9 %	1,155	76.8 %	1,174	76.9 %	+1.62%
Overseas 23.1 %	348	23.2 %	354	23.1 %	+1.49%

Managers	Title	Age	Since
Yong Wang CEO	Chief Executive Officer	57	29/06/09
Xiao Ting Wang DFI	Director of Finance/CFO	42	24/05/22
Hai Bin Li BRD	Director/Board Member	53	31/01/16
Xu Li BRD	Director/Board Member	39	02/12/18
Fen Zhang IRC	Investor Relations Contact	-	-
Xin Zhe Yang SEC	Corporate Secretary	51	15/11/18

Members of the board	Title	Age	Since
Hong Jia Gong CHM	Chairman	59	25/03/22
Yong Wang CEO	Chief Executive Officer	57	29/06/09
Xin Yi Hou BRD	Director/Board Member	64	18/05/20
Yan Wang CHM	Chairman	53	15/05/23
Hong Qi Wang BRD	Director/Board Member	59	15/05/23
Hai Bin Li BRD	Director/Board Member	53	31/01/16
Shan Wu BRD	Director/Board Member	43	02/12/18
Duan Qing Pei BRD	Director/Board Member	59	18/05/20
Xin Tong Li BRD	Director/Board Member	30	15/05/23
Li Tianyi BRD	Director/Board Member	36	15/05/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	471,418,790	337,719,549 ( 71.64 %)	3,469,900 ( 0.7361 %)	71.64 %

Name	Equities	%	Valuation
De Fu Li 12.20 %	57,078,420	12.20 %	130 M ¥
Shenzhen Jiadaogu Investment Management Co. Ltd. 9.608 %	44,943,820	9.608 %	102 M ¥
China Cinda Asset Management Co., Ltd. (Investment Company) 4.746 %	22,200,000	4.746 %	50 M ¥
UBS Asset Management Switzerland AG 2.534 %	11,851,764	2.534 %	27 M ¥
Hui Wang 1.381 %	6,457,900	1.381 %	15 M ¥
Chun Mei Chen 1.232 %	5,761,349	1.232 %	13 M ¥
Qian Qian Yang 0.9415 %	4,404,200	0.9415 %	10 M ¥
Yulong Ma 0.7641 %	3,574,000	0.7641 %	8 M ¥
Xiao Ge Wang 0.7631 %	3,569,785	0.7631 %	8 M ¥
Zhi Lin Xu 0.6943 %	3,247,863	0.6943 %	7 M ¥

Vcanbio Cell & Gene Engineering Corp., Ltd.

Huayuan Industrial Park 12 Meiyuan Road

300384, Tianjin

+86 22 5877 5766

http://www.vcanbio.com

address Vcanbio Cell & Gene Engineering Corp., Ltd(600645)

Name	Category and Sector
Tianjin Yuanjufu Enterprise Management Partnership (LP)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
VCANBIO CELL & GENE ENGINEERING CORP., LTD	-12.19%	1.15B
BIOMÉRIEUX	-1.89%	12.5B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.67B
LANTHEUS HOLDINGS, INC.	+21.82%	5.36B
DIASORIN S.P.A.	-1.31%	5.26B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-50.89%	3.15B
ANDON HEALTH CO., LTD.	+6.42%	2.59B
VITROLIFE AB	-10.02%	2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B

Diagnostic & Testing Substances